XML 64 R53.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities $ (1,155) $ (8,684)
Net cash (used) provided by operating activities (8,775) 86,821
Payments to Acquire Businesses, Gross 27,742 0
Investing Activities:    
Capital expenditures (21,402) (16,384)
Net cash used in investing activities (50,299) (25,068)
Financing Activities:    
Proceeds from (Repayments of) Bank Overdrafts 14,676 (9,408)
Payments for Repurchase of Common Stock (152,722) (1,891)
Proceeds from (Payments for) Other Financing Activities (472) (550)
Net cash used in financing activities 50,015 (63,749)
Effect of exchange rate changes on cash and cash equivalents (66) (5,017)
Net change in cash and cash equivalents (9,125) (7,013)
Cash and cash equivalents at the beginning of period 96,343 117,953
Cash and cash equivalents at the end of period 87,218 110,940
Parent Company [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 0 0
Net cash (used) provided by operating activities 4,904 9,878
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received 0 0
Net cash used in investing activities 0 0
Financing Activities:    
Borrowings 147,818 0
Repayments 0 (7,987)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock (152,722) 1,891
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (4,904) (9,878)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period 0 0
Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (192,235) (37,524)
Net cash (used) provided by operating activities 128,070 31,192
Payments to Acquire Businesses, Gross (27,742)  
Investing Activities:    
Capital expenditures (5,843) (9,334)
Proceeds from Dividends Received 44,417 95,511
Net cash used in investing activities (181,403) 48,653
Financing Activities:    
Borrowings 242,134 191,888
Repayments (193,134) (260,888)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock   0
Payments for Repurchase of Private Placement 0  
Proceeds from (Payments for) Other Financing Activities 2,803 (9,958)
Net cash used in financing activities 51,803 (78,958)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents (1,530) 887
Cash and cash equivalents at the beginning of period 35,931 50,602
Cash and cash equivalents at the end of period 34,401 51,489
Non-Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (1,155) (8,684)
Net cash (used) provided by operating activities (141,749) 45,751
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures (15,559) (7,050)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (16,714) (15,734)
Financing Activities:    
Borrowings 720,657 736,372
Repayments (525,306) (673,761)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (44,417) (95,511)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities 150,934 (32,900)
Effect of exchange rate changes on cash and cash equivalents (66) (5,017)
Net change in cash and cash equivalents (7,595) (7,900)
Cash and cash equivalents at the beginning of period 60,412 67,351
Cash and cash equivalents at the end of period 52,817 59,451
Consolidated Entities [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (1,155) (8,684)
Net cash (used) provided by operating activities (8,775) 86,821
Payments to Acquire Businesses, Gross (27,742)  
Investing Activities:    
Capital expenditures (21,402) (16,384)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (50,299) (25,068)
Financing Activities:    
Borrowings 918,374 882,749
Repayments (718,440) (934,649)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock 152,722 1,891
Proceeds from (Payments for) Other Financing Activities 2,803 (9,958)
Net cash used in financing activities 50,015 (63,749)
Effect of exchange rate changes on cash and cash equivalents (66) (5,017)
Net change in cash and cash equivalents (9,125) (7,013)
Cash and cash equivalents at the beginning of period 96,343 117,953
Cash and cash equivalents at the end of period 87,218 110,940
Consolidation, Eliminations [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 192,235 37,524
Net cash (used) provided by operating activities 0 0
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received (44,417) (95,511)
Net cash used in investing activities 147,818 (57,987)
Financing Activities:    
Borrowings (192,235) (45,511)
Repayments 0 (7,987)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (44,417) (95,511)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (147,818) 57,987
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period $ 0 $ 0